1. Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial. Issue 5 (May 2016) Authors: Nywening, Timothy M; Wang-Gillam, Andrea; Sanford, Dominic E; Belt, Brian A; Panni, Roheena Z; Cusworth, Brian M; Toriola, Adetunji T; Nieman, Rebecca K; Worley, Lori A; Yano, Motoyo; Fowler, Kathryn J; Lockhart, A Craig; Suresh, Rama; Tan, Benjamin R; Lim, Kian-Huat; Fields, Ryan C; Strasberg, S... Journal: Lancet oncology Issue: Volume 17:Issue 5(2016:May) Page Start: 651 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗